Cite
Callens C, Vaur D, Soubeyran I, et al. Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial. J Natl Cancer Inst. 2021;113(7):917-923doi: 10.1093/jnci/djaa193.
Callens, C., Vaur, D., Soubeyran, I., Rouleau, E., Just, P. A., Guillerm, E., Golmard, L., Goardon, N., Sevenet, N., Cabaret, O., Harter, P., Gonzalez-Martin, A., Fujiwara, K., Cecere, S. C., Colombo, N., Marth, C., Vergote, I., Maenpaa, J., Pujade-Lauraine, E., & Ray-Coquard, I. (2021). Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial. Journal of the National Cancer Institute, 113(7), 917-923. https://doi.org/10.1093/jnci/djaa193
Callens, Céline, et al. "Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial." Journal of the National Cancer Institute vol. 113,7 (2021): 917-923. doi: https://doi.org/10.1093/jnci/djaa193
Callens C, Vaur D, Soubeyran I, Rouleau E, Just PA, Guillerm E, Golmard L, Goardon N, Sevenet N, Cabaret O, Harter P, Gonzalez-Martin A, Fujiwara K, Cecere SC, Colombo N, Marth C, Vergote I, Maenpaa J, Pujade-Lauraine E, Ray-Coquard I. Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial. J Natl Cancer Inst. 2021 Jul 01;113(7):917-923. doi: 10.1093/jnci/djaa193. PMID: 33372675; PMCID: PMC8246800.
Copy
Download .nbib